EUROPEAN shares ended Monday’s choppy session in the red ahead of a series of marquee corporate earnings, although ...

Sanofi will sell a 50% controlling stake in consumer healthcare unit Opella to private equity firm CD&R, with the French ...

French drugmaker Sanofi’s confirmation yesterday that it plans to sell a controlling stake in its over-the-counter unit to a ...

Sanofi is now in “exclusive negotiations” with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50% ...

Truelink Capital has agreed to acquire GES, a Las Vegas-based provider in the global exhibition and event industry. The seller is Viad Corp. The purchase price is $535 million. The deal is expected to ...

A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...

Sanofi agrees to sell a 50% stake in Opella to CDR for €15bn, securing job promises. Discover the impact on France ...

Global investment firm CD&R announced an open offer to buy a 26% stake in Sanofi Consumer Healthcare India for Rs 2,983 crore ...

Miracle cures are few and far between. The best one can hope for is partial relief. So it is with Sanofi’s consumer health split. The French pharma group’s sale of a majority 50 per cent stake in its ...

Global investment firm CD&R on Monday announced an open offer to acquire a 26 per cent stake in Sanofi Consumer Healthcare India Ltd for an aggregate of up to Rs 2,983 crore. The development follows ...

An international investment company, CD&R, has announced plans to acquire a 26% stake in Sanofi Consumer Healthcare India Ltd ...

Paladin Capital has appointed Nazo Moosa as managing director of its European operations. Moosa joins Paladin’s UK office and ...